Cytiva
Empowering the future of biopharmaceutical development with innovative technologies and decades of expertise
Company Overview
Cytiva is a global provider of technologies and services that accelerate the development and manufacturing of therapeutics. Formed from the former Life Sciences business of GE Healthcare and acquired by Danaher Corporation in 2020, Cytiva continues a legacy of innovation spanning more than 80 years.
The company's comprehensive portfolio addresses every stage of the biopharmaceutical lifecycle, from early research through clinical development to commercial manufacturing. Cytiva's solutions are used in the production of many of today's most important biopharmaceuticals, including treatments for cancer, autoimmune diseases, and rare disorders.
With a customer-centric approach and deep process knowledge, Cytiva partners with biopharmaceutical companies to improve productivity, reduce costs, and bring life-saving therapies to patients faster.
80+
Years Legacy
100+
Therapies Supported
6,000+
Employees Globally
30+
Manufacturing Sites
Core Product Lines
Chromatography Resins
High-performance media for protein purification including affinity, ion exchange, hydrophobic interaction, and size exclusion chromatography.
- •Protein A ligands
- •Capto™ resins
- •Sepharose™ beads
- •Pre-packed columns
Depth Filtration
Clarification solutions for cell culture harvest and fermentation broth processing with optimized retention and throughput.
- •Clarify™ depth filters
- •Multiple grades
- •Scalable formats
- •High capacity
Tangential Flow Filtration
Crossflow filtration systems for concentration, diafiltration, and fractionation of biomolecules from lab to production scale.
- •Hollow fiber cartridges
- •Ultracel™ membranes
- •Kros® modules
- •Complete systems
Bioreactors & Fermenters
Single-use and stainless steel bioreactor systems for cell culture and microbial fermentation from development to manufacturing.
- •Xcellerex™ systems
- •Ambr® microcarriers
- •Process control
- •Scalability
Cell Culture Media
Chemically defined and protein-free media formulations for mammalian cell culture supporting high titers and product quality.
- •CDM4CHO™ media
- •Feed supplements
- •Custom formulations
- •Tech support
Analytical & QC Solutions
Instruments and consumables for characterization, quality control, and process monitoring throughout biopharmaceutical development.
- •Biacore™ systems
- •Octet® platforms
- •Label-free detection
- •Kinetic analysis
Technology Advantages
Integrated Bioprocessing Platforms
Comprehensive solutions connecting upstream and downstream operations with compatible products, reducing complexity and improving process efficiency.
Accelerated Process Development
High-throughput screening tools and DoE support enabling rapid optimization of purification processes with minimal material consumption.
Cell Therapy Expertise
Specialized solutions for cell and gene therapy manufacturing including closed systems, viral vector purification, and process characterization.
Digital Solutions & Analytics
Advanced analytics platforms and digital tools for real-time process monitoring, data management, and decision support.
Key Application Areas
Monoclonal Antibodies & Biosimilars
Upstream cell culture, harvest, Protein A capture, polishing, viral filtration
Vaccines & Viral Vectors
Cell line development, production optimization, purification, formulation
Recombinant Proteins
Expression optimization, multi-step purification, concentration, buffer exchange
Cell & Gene Therapies
Lentivirus/AAV production, plasmid DNA purification, cell expansion, final product
Partner with Cytiva
Leverage Cytiva's comprehensive bioprocessing portfolio and application expertise to accelerate your drug development programs.
Get Started